Terms: = Endocrine gland cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
154 results:
1. Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology.
Kango G; Malek R; Mannuel H; Hussain A
Curr Opin Oncol; 2024 May; 36(3):195-201. PubMed ID: 38573209
[TBL] [Abstract] [Full Text] [Related]
2. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract] [Full Text] [Related]
3. A meta-analysis of total thyroidectomy and lobectomy outcomes in papillary thyroid microcarcinoma.
Bi J; Zhang H
Medicine (Baltimore); 2023 Dec; 102(50):e36647. PubMed ID: 38115346
[TBL] [Abstract] [Full Text] [Related]
4. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
[TBL] [Abstract] [Full Text] [Related]
5. Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.
Ganju V; Marx G; Pattison S; Amaro-Mugridge NB; Zhao JT; Williams BRG; MacDiarmid JA; Brahmbhatt H
Clin Cancer Res; 2024 Jan; 30(2):304-314. PubMed ID: 37976042
[TBL] [Abstract] [Full Text] [Related]
6. Risk-stratified Distant Metastatic Thyroid cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
Cheng X; Zhou Y; Xu S; Yu H; Wu J; Bao J; Zhang L
Exp Clin Endocrinol Diabetes; 2023 Nov; 131(11):577-582. PubMed ID: 37922948
[TBL] [Abstract] [Full Text] [Related]
7. Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic cancer.
Sang W; Zhou Y; Chen H; Yu C; Dai L; Liu Z; Chen L; Fang Y; Ma P; Wu X; Kong H; Liao W; Jiang H; Qian J; Wang D; Liu YH
Cancer Discov; 2024 Feb; 14(2):326-347. PubMed ID: 37824278
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study.
Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a nomogram for assessment postoperative sodium disturbance in PAs patients: a retrospective cohort study.
Li W; Tang D; Wang Q; Li S; Zhao W; You L
PeerJ; 2023; 11():e15946. PubMed ID: 37663278
[TBL] [Abstract] [Full Text] [Related]
10. Integrating US-guided FNAB, BRAF
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract] [Full Text] [Related]
11. Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic cancer Resection.
van Oosten AF; Groot VP; Dorland G; Burkhart RA; Wolfgang CL; van Santvoort HC; He J; Molenaar IQ; Daamen LA
Ann Surg; 2024 Mar; 279(3):493-500. PubMed ID: 37389896
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors.
Reinhard L; Mogl MT; Benz F; Dukaczewska A; Butz F; Dobrindt EM; Tacke F; Pratschke J; Goretzki PE; Jann H
Langenbecks Arch Surg; 2023 Jun; 408(1):237. PubMed ID: 37332044
[TBL] [Abstract] [Full Text] [Related]
13. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
Mauguen A; Grewal RK; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne J; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Tuttle RM; Ho A; Humm JL; Larson SM
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2971-2983. PubMed ID: 37171634
[TBL] [Abstract] [Full Text] [Related]
14. Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Vassallo A; Weber MF; Steinberg J; Webb PM; DeFazio A; Canfell K
PLoS One; 2023; 18(4):e0282851. PubMed ID: 37071628
[TBL] [Abstract] [Full Text] [Related]
15. Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
Foster KI; Shaw KRM; Jin J; Westin SN; Yap TA; Glassman DM; Jazaeri AA; Rauh-Hain JA; Lee S; Fellman BM; Ju Z; Liu Y; Fleming ND; Sood AK
Cancer; 2023 Jun; 129(11):1672-1680. PubMed ID: 36930815
[TBL] [Abstract] [Full Text] [Related]
16. Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability.
Tang J; Sheng J; Zhang Q; Ji Y; Wang X; Zhang J; Wu J; Song J; Bai X; Liang T
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36849200
[TBL] [Abstract] [Full Text] [Related]
17. Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
Sandilos G; Lou J; Butchy MV; Gaughan JP; Reid L; Spitz FR; Beninato T; Moore MD
Am J Surg; 2023 Jul; 226(1):53-58. PubMed ID: 36775791
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of the Safety and Pregnancy Outcomes of Fertility-sparing Surgery in Ovarian Malignant Sex Cord-stromal Tumours: A Multicentre Retrospective Study.
Li J; Chu R; Wang Z; Chen G; Shen Y; Lou Y; Li L; Sun C; Li K; Song L; Qin T; Li J; Yin Y; Chen Z; Liu P; Song K; Kong B
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e206-e214. PubMed ID: 36494251
[TBL] [Abstract] [Full Text] [Related]
19. Investigation of cytotoxic and apoptotic effects of disodium pentaborate decahydrate on ovarian cancer cells and assessment of gene profiling.
Gunel NS; Yildirim N; Ozates NP; Oktay LM; Bagca BG; Sogutlu F; Ozsaran A; Korkmaz M; Biray Avci C
Med Oncol; 2022 Oct; 40(1):8. PubMed ID: 36308567
[TBL] [Abstract] [Full Text] [Related]
20. Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.
Monzani ML; Piccinini F; Boselli G; Corleto R; Margiotta G; Peeters RP; Simoni M; Brigante G
J Endocrinol Invest; 2023 Feb; 46(2):319-326. PubMed ID: 35988109
[TBL] [Abstract] [Full Text] [Related]
[Next]
